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Abstract 
 
Background: Pemphigus is a chronic autoimmune blistering disease of the skin and mucosa 
severely impairing patients’ health-related quality of life (HRQoL). To date, no studies have 
measured subjective well-being in terms of life satisfaction in pemphigus. Our main objective 
was to evaluate satisfaction with life in patients with pemphigus, and to analyse its relationship 
with clinical severity and HRQoL. 
Methods: A cross-sectional survey was carried out enrolling 77 patients with pemphigus. 
Subjective well-being was measured by using the Satisfaction with Life Scale (SWLS). HRQoL 
was assessed by the Dermatology Life Quality Index (DLQI) and EQ-5D-5L. Disease severity 
was measured by Autoimmune Bullous Skin Disorder Intensity Score (ABSIS).  
Results: Mean ABSIS, DLQI, EQ-5D-5L and SWLS scores of patients were 11.7 (SD 17.3), 
5.4 (6.8), 0.84 (0.22) and 4.76 (SD 1.52), respectively. The proportion of patients indicating 
extreme dissatisfaction, dissatisfaction, slightly below average in life satisfaction, average 
satisfaction, high satisfaction and very high satisfaction with life was 6 (7.8%), 5 (6.5%), 14 
(18.2%), 16 (20.8%), 21 (27.3%) and 15 (19.5%), respectively. Life satisfaction was 
independent from age, gender, level of education and type of disease. A path analysis revealed 
that there was no direct relationship between ABSIS and SWLS (beta=-0.09; p=0.428); 
however, the following indirect path was confirmed: ABSIS–> DLQI->EQ-5D-5L–>SWLS. 
Conclusions: Disease severity and HRQoL measures regularly used to assess patients’ health 
status may be complemented with a measure of subjective well-being, such as SWLS, in order 
to achieve a more holistic assessment of patients’ lives and optimise pemphigus care.  
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Pemphigus is a rare, autoimmune blistering disease with two major subtypes pemphigus 
vulgaris and pemphigus foliaceus [1]. Pemphigus vulgaris accounts for approximately 70-90% 
of all cases with an annual incidence rate of 0.76 to 32 per million [2,3]. Mean age of onset is 
usually between 50 and 60 years. Pemphigus causes blisters and erosions developing on the 
skin or mucous membranes, such as in the mouth. Physical symptoms include itching, skin 
burning and pain. Pemphigus has a strong influence on patients’ health related quality of life 
(HRQoL), but it largely affects other aspects of patients’ life, such as social activities or 
productivity [4-6]. It has been shown that pemphigus is associated with one of the largest 
HRQoL impairment among chronic skin diseases [4,5,7-9].  
 
Recently, subjective well-being has gained increasing attention in health policy. Subjective 
well-being reflects an overall evaluation of the quality of a person’s life from their own 
perspective [10]. Evidence on subjective measures of well-being is in the focus of interest to 
provide a basis for reimbursement decisions about health technologies [11]. To use well-being 
outcomes in resource allocation decisions, the relationship between subjective well-being and 
the different dimensions of health, such as clinical symptoms, disease-specific and general 
HRQoL, needs to be explored [12]. Life satisfaction is a core indicator of people’s subjective 
well-being. Satisfaction with life can be used as an outcome measure, as it is directly related to 
HRQoL.  In patients suffering from chronic diseases, both physical and mental problems may 
have a substantial negative impact on satisfaction with life [13]. 
 
Patients’ interpersonal relationships, social activities, sexual life and self-esteem are commonly 
adversely affected by chronic dermatological diseases [14]. In addition, patients may be 
dissatisfied with treatments and healthcare in general. Unemployment rate was also found 
higher in chronic skin diseases compared to health controls, and a proportion of patients also 
face a lower earning potential [15-18]. Dissatisfaction with life has been earlier reported in 
patients with atopic dermatitis, psoriasis, hidradenitis suppurativa, melanoma, systemic lupus 
erythematosus and urticaria [19-25]. Life satisfaction, however, has not yet been measured in 
pemphigus patients. Therefore, our main objective was to evaluate the satisfaction with life in 
patients with pemphigus and to analyse the relationship between severity of clinical symptoms, 
HRQoL and life satisfaction as an indicator of subjective well-being. 
 
Methods 
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Study population and setting 
Between December 2014 and June 2017, a cross-sectional study was conducted in four 
academic dermatology departments in Hungary. Consecutive patients over 18 years of age 
diagnosed with any form of pemphigus were enrolled after an informed consent form was read 
and signed. Permission for conducting the study was granted by the National Scientific and 
Ethical Committee (reference No. ETT-TUKEB 27416-3/2016/EKU).  
First part of the survey asked patients about demographics, employment status, self-reported 
disease severity, utilisation of healthcare services in the past 12 months, HRQoL, and 
satisfaction with life. Dermatologists filled in the second part of the questionnaire. Based on 
medical records they provided data on clinical characteristics, medications, medical history and 
disease severity. 
 
 
Outcome measures 
 
EQ-5D-5L  
EQ-5D-5L is a widely used generic instrument to assess general HRQoL [26,27]. It consists of 
two parts: a descriptive system and a visual analogue scale (EQ VAS). The descriptive system 
involves the following five dimensions of general HRQoL: mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression. For each dimension, patients may choose from five 
response levels (no problems = 1, slight problems = 2, moderate problems = 3, severe problems 
= 4 and unable to/extreme problems = 5) resulting in a total of 3125 (55) unique health states. 
In absence of a national value set in Hungary, the value set for England developed by Devlin et 
al. was applied in this study to derive EQ-5D index scores [28]. Thus, index scores may range 
from -0.285 to +1, where -0.285 corresponds to the worst and +1 to the best possible HRQoL. 
The second part of the instrument, EQ VAS is a 20-cm long, vertical visual analogue scale with 
endpoints of ‘0’ (the worst health you can imagine) and ‘100’ (the best you can imagine) 
recording patients’ self-rating of their overall health. 
 
 
DLQI 
Dermatology Life Quality Index (DLQI) is a skin-specific self-reported questionnaire [29,30]. 
It consists of ten items covering the common problems affecting HRQoL of patients with skin 
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diseases, such as symptoms, side effects of treatment, daily activities, work or school, personal 
relationships, leisure activities, and feelings of embarrassment. Each item is scored on a 4-point 
scale: ‘not at all’ or ‘not relevant’=0, ‘a little’=1, ‘a lot’=2 and ‘very much’=3. DLQI total score 
is calculated by summing the score of each question resulting in a maximum of 30 and a 
minimum of 0, where the higher the score, the more HRQoL is impaired. 
 
SWLS 
The Satisfaction with Life Scale (SWLS) is an extensively used questionnaire to quantify 
people’s global judgement on their the subjective well-being [31]. The Hungarian version of 
SWLS showed a good internal consistency reliability (Cronbach’s α 0.84), convergent validity 
with the Rosenberg Self-esteem Scale and the Purpose in Life Test and an excellent test-retest 
reliability [32]. SWLS is a 5-item instrument each of which is rated on a 7-point scale ranging 
from ‘strongly disagree’ to ‘strongly agree’. The total score was estimated as the average of the 
five items resulting in a score between 1 and 7, where a higher score reflects a greater life 
satisfaction for the individual [31]. The following cut-off scores were used to classify patients 
into SWLS groups: 1-2 (’extremely dissatisfied’), 2-3 (’dissatisfied’), 3-4 (’slightly below 
average satisfaction’), 4-5 (’average satisfaction’), 5-6 (’satisfied’) and 6-7 (’highly satisfied’) 
[33]. 
 
 
ABSIS 
Severity of pemphigus was graded by using the Autoimmune Bullous Skin Disorder Intensity 
Score (ABSIS) [34-36]. The ABSIS total score ranges between 0 and 206, where a higher score 
indicates more severe disease. Subgroups of disease severity were defined based on the 
following cut-off values: limited (ABSIS 0-3), moderate (ABSIS 4-16), significant (ABSIS 17-
52) and extensive (ABSIS 53-206) pemphigus [37]. 
 
Statistical analysis 
First, sample and SWLS item characteristics were computed. As a preliminary analysis, 
Pearson’s correlation coefficients were calculated to explore the relationships between the 
outcome measures. A correlation coefficient of 0-0.39 was defined as weak, 0.40-0.79 as 
moderate, and 0.80-1 as a strong correlation. The differences in SWLS scores between 
subgroups of patients were compared by using Mann-Whitney U test.  
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We conducted a path analysis to test a hypothesized model predicting SWLS scores from EQ-
5D-5L index, DLQI, ABSIS scores. Among the four variables the following six paths were 
hypothesized and tested: (1) ABSIS → DLQI (+); (2) ABSIS → EQ-5D-5L (–); (3) ABSIS → 
SWLS (–); (4) DLQI → EQ-5D-5L (–); (5) DLQI → SWLS (–) and (6) EQ-5D-5L → SWLS 
(+). To determine whether the expected model was plausible with the data, we used a Chi-
square test statistic. The following goodness-of-fit indices were used based on Hu and Bentler’s 
recommendations: comparative fit index (CFI), root mean square error of approximation 
(RMSEA), and standardized root mean square residual (SRMR) [38]. A CFI of > 0.95 was 
considered as an indicative of good fit. Acceptable threshold values of RMSEA and SRMR 
were ≤0.06 and ≤0.08, respectively. P-values less than 0.05 were taken as statistically 
significant. The path analysis was conducted by using AMOS 23, all other analyses were 
performed by using SPSS 25.0 (Armonk, NY: IBM Corp.). 
 
Results 
 
General characteristics 
A total of 77 patients completed the SWLS, DLQI and EQ-5D-5L questionnaires. 
Characteristics of the patient population are presented in Table 1. Mean age was 55.4 (SD 14.8) 
years, and 58% were female. The majority of patients (73%) were diagnosed with pemphigus 
vulgaris and 26% with pemphigus foliaceus. One patient had IgA pemphigus. Mean ABSIS 
score of the study population was 11.7 (SD 17.3). Based on ABSIS, 37 (48%), 20 (26%), 16 
(21%) and 4 (5%) patients were grouped into mild, moderate and significant and extensive 
pemphigus subgroups. Mean EQ-5D-5L index and EQ VAS scores were 0.84 (0.22) and 69 
(22), respectively.  
 
Descriptive statistics of SWLS 
 
Distribution of responses on the five items of SWLS is presented in Figure 1. The highest rate 
of ‘strongly agree’ responses was found for items 1, 3 and 5 (19%), while the highest rate of 
‘strongly disagree’ responses was observed for item 5. The mean SWLS total score in the 
sample was 4.76 (SD 1.52). All five items exhibited very similar means: item 1: “In most ways, 
my life is close to my ideal” (4.83, SD 1.76), item 2: “The conditions of my life are excellent” 
(4.63, SD 1.80), item 3: “I am satisfied with my life” (4.92, SD 1.77), item 4:”So far I have 
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gotten the important things I want in my life” (4.7, SD 1.58) and item 5: “If I could live my life 
over, I would change almost nothing” (4.55, SD 1.85). 
Six (7.8%) patients indicated extreme dissatisfaction, 5 (6.5%) dissatisfaction, 14 (18.2%) 
slightly below average in life satisfaction, 16 (20.8%) average satisfaction, 21 (27.3%) high 
satisfaction and 15 (19.5%) very high satisfaction with their lives, respectively. 
 
 
Correlation analysis 
Table 2 reports the correlations among ABSIS, DLQI, EQ-5D-5L and SWLS total scores. 
Moderate correlations were found between ABSIS and DLQI (r=0.425, p<0.001), between 
DLQI and EQ-5D-5L (r=-0.593, p<0.001) and between EQ-5D-5L and SWLS (r=0.465, 
p=0.011).  ABSIS  demonstrated a weak correlation with EQ-5D-5L (r=-0.345, p=0.002) and 
with SWLS (r=-0.237, p=0.038). A weak correlation was detected between DLQI and SWLS 
(r=-0.288, p=0.011). 
 
Subgroup analysis of SWLS 
Table 3 presents the total SWLS scores in subgroups of patients based on gender, age, education 
and type of pemphigus. Slightly higher mean SWLS scores were observed in females (4.82), 
patents aged >65 (4.91), those with a college or university degree (5.05) and pemphigus 
foliaceus patients (4.93); however, the differences were insignificant. 
 
Results of the path analysis model 
The path analysis model we evaluated is depicted in Figure 2. The results indicate that there 
was a statistically significant path from ABSIS->DLQI->EQ-5D-5L->SWLS. The model 
showed overall good fit indices: Chi-square=0.00 CFI = 1.00, SRMR = 0.00. The model 
explained 18.0% of the variance of DLQI, 36.2% of the EQ-5D-5L and 22.3 % of the SWLS. 
 
ABSIS had a positive effect on DLQI ( = 0.425; p<0.001) indicating that the disease severity 
assessed by the dermatologist affects the skin-specific HRQoL perceived by the patient. The 
ABSIS scores demonstrated no direct impact on EQ-5D-5L index scores ( =-0.114; p=0.262). 
An indirect path was detected between ABSIS and EQ-5D-5L index through DLQI score. 
Contrary to our expectations, there was no direct relationship between ABSIS and SWLS (=-
0.090; p=0.428). DLQI had a negative effect on EQ-5D-5L (=-0.545; p<0.001) implying that 
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skin-specific HRQoL did influence general HRQoL. There was no direct relationship between 
DLQI and SWLS (=0.011; p=0.935). However an indirect patch was detected by which the 
DLQI affected SWLS through the EQ-5D-5L. Finally, a significant relationship was found 
between EQ-5D-5L and SWLS (=0.440; p<0.001). 
 
 
Discussion 
The aim of the present study was to investigate life satisfaction as a proxy for subjective well-
being and its predictors in pemphigus patients through a path analysis. The mean SWLS score 
was 4.76 indicating an overall average satisfaction with life. Nearly one-third (32.3%) of 
patients rated their satisfaction with their life to be ‘below average’. Life satisfaction was 
independent from patients’ age, gender, level of education and type of disease. A path analysis 
revealed the following indirect path: ABSIS –> DLQI -> EQ-5D-5L –> SWLS. Physician’s 
objective assessment of disease severity (ABSIS) had no direct impact on life satisfaction. This 
route highlights the mediating effect of the patients’ perception about HRQoL on satisfaction 
with life. 
 
Coping with the daily limitations caused by a chronic disease often affects patients’ perception 
of health and satisfaction with life [39]. Previous research has shown significantly lower life 
satisfaction in patients with various chronic skin diseases [19-25]. For example, 16.6% of 
patients with atopic dermatitis in the US reported being at least somewhat dissatisfied with life 
[25]. In our study, 14.3% of patients declared to be dissatisfied or highly dissatisfied. A 
potential explanation for this could be that the majority of patients were well-treated and 
indicated a relatively low disease severity and less deterioration in their HRQoL, which was 
very likely responsible for the rather positive results regarding life satisfaction.  
 
Earlier research suggests a good validity of the EQ-5D-5L in pemphigus patients [8]. 
Nevertheless, it may fail to capture some of the broader impact of pemphigus on HRQoL and 
subjective well-being [11]. For example, in a recent survey among members of the general 
population in the UK, respondents identified several important aspects of health that are not 
covered by the five dimensions of the EQ-5D, such as mental and emotional health and 
happiness [40]. Non-health outcomes including ability to work, financial security and social 
support in one’s life might be important determinants of life satisfaction. 
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A practical implication of our study is that objective perception of the physician on disease 
severity only has an indirect effect on satisfaction with life. In routine practice, disease severity 
and HRQoL instruments regularly used to assess patients’ health status may be complemented 
with a measure of subjective well-being, such as SWLS in order to achieve a more holistic 
assessment of patients’ lives and optimise pemphigus care. This would also enable the use of 
subjective well-being outcomes to aid health policy decisions.  
 
This is the first study in the literature to report on life satisfaction in pemphigus patients. 
Furthermore, our analyses were based on a relatively large number of patients, considering the 
rarity of the disease. Among the study’s limitations, it needs to be acknowledged that the study 
was conducted in university dermatology departments, and systematic selection bias due to 
centre effects could have been present. Thus, the results may not be representative of the entire 
population of patients with pemphigus. However, the study population included a large variety 
of pemphigus patients in terms of clinical characteristics and severity. Secondly, many other 
factors possibly influencing life satisfaction has not been measured in this survey. Further 
research is required to identify unexplored the drivers of subjective well-being in pemphigus 
patients. 
In conclusion, an overall average satisfaction with life was identified in patients with 
pemphigus. A higher level of general HRQoL is the major determinant of life satisfaction in 
pemphigus patients. The path analysis identified skin-specific HRQoL and disease severity as 
indirect predictors of satisfaction with life. These results underscore the importance of 
achieving remission in benefiting the lives of patients with pemphigus. 
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Figure captions 
Figure 1 Distribution of the responses on the 5 items of SWLS 
SWLS = Satisfaction with Life Scale 
 
Figure 1 Path model  
Notes: Every path coefficient is standardized (*p < 0.001). Dashed lines represent insignificant paths. 
ABSIS = Autoimmune Bullous Skin Disorder Intensity Score; DLQI = Dermatology Life Quality Index; SWLS = 
Satisfaction with Life Scale. 
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Table 1 General characteristics of the sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Combinations are possible. 
ABSIS = Autoimmune Bullous Skin Disorder Intensity Score; DLQI = Dermatology Life Quality Index; SWLS 
= Satisfaction with Life Scale. 
 
 
 
 
  
Characteristics 
N (%) or mean (SD) 
Number of subjects 77 
Age (years)  55.4 (14.8) 
Female  45 (58.4%) 
Education  
Primary school  13 (16.9%) 
High school 42 (54.5%) 
College/university  22 (28.6%) 
Employment*   
Employed full-time 29 (37.7%) 
Employed part-time 8 (10.4%) 
Unemployed 4 (5.2%) 
Disability pensioner 12 (15.6%) 
Retired 27 (35.1%) 
Student 1 (1.3%) 
Other 1 (1.3%) 
Disease duration (years) 4,4 (5.3) 
Type of pemphigus  
Pemphigus vulgaris   56 (72.7%) 
Pemphigus foliaceus   20 (26.0%) 
IgA pemphigus 1 (1.3%) 
ABSIS (0-206) 12.6 (18.9%) 
Severity groups  
Limited (ABSIS 0-3) 37 (48.1%) 
Moderate (ABSIS 4-16) 20 (26.0%) 
Significant (ABSIS 17-52) 16 (20.8%) 
Extensive (ABSIS 53-206) 4 (5.2%) 
DLQI (0-30) 5.36 (6.88) 
EQ-5D-5L (-0.285-1) 0.84 (0.22) 
Current treatment  
None 2 (2.6%) 
Topical therapy (only) 7 (9.1%) 
Systemic therapy* 68 (88.3%) 
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Table 2 Correlation matrix of the outcome measures 
 ABSIS DLQI EQ-5D-5L 
ABSIS (0-206) - - - 
DLQI (0-30) 0.425 (p<0.001) - - 
EQ-5D-5L (-0.285-1) -0.345 (p=0.002) -0.593 (p<0.001) - 
SWLS (1-7) -0.237 (p=0.038) -0.288 (p=0.011) 0.465 (p=0.011) 
ABSIS = Autoimmune Bullous Skin Disorder Intensity Score; DLQI = Dermatology Life Quality Index; SWLS = 
Satisfaction with Life Scale. 
For ABSIS and DLQI, higher scores represent worse health status and for EQ-5D-5L and SWLS higher scores 
refer to better health status/satisfaction with life. 
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Table 3 SWLS scores in subgroups of patients 
 Mean (SD) Median (IQR) p-value 
Gender   p = 0.688 
Male 4.68 (1.34) 4.90 (2.05)  
Female 4.82 (1.65) 5.20 (2.40)  
Age groups   p=0.181 
18-45 5.22 (1.45) 5.3 (1.8)  
46-65 4.45 (1.59) 4.7 (2.2)  
66- 4.91 (1.39) 5.2 (2.3)  
Education   p = 0.577 
Primary 4.58 (2.11) 4.80 (4.00)  
Secondary 4.66 (1.46) 4.80 (2.20)  
Tertiary 5.05 (1.25) 5.20 (1.75)  
Type of 
pemphigus 
  p = 0.562 
Pemphigus 
vulgaris
  
4.70 (1.59) 5.00 (2.20)  
Pemphigus 
foliaceus 
4.93 (1.34) 5.00 (2.20)  
SWLS = Satisfaction with Life Scale 
 
